Cogent Biosciences, Inc. COGT Other comprehensive income (loss)
Other comprehensive income (loss) at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossNetOfTax.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s other comprehensive income (loss).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s other comprehensive income (loss)?
- Cogent Biosciences, Inc. (COGT) reported other comprehensive income (loss) of -$770K in Q1 2026.
- How has Cogent Biosciences, Inc.'s other comprehensive income (loss) changed year-over-year?
- Cogent Biosciences, Inc.'s other comprehensive income (loss) decreased by 172.1% year-over-year, from -$283K to -$770K.
- What does other comprehensive income (loss) mean?
- This metric represents the total change in equity resulting from non-owner sources that are excluded from the traditional net income calculation. It includes items such as unrealized gains or losses on securities and foreign currency translation adjustments. It provides a more comprehensive view of the company's financial position beyond standard operational performance.